Investor Presentaiton

Anvisa Review Process of Registration Dossier Applicant submits registration dossier to ANVISA EXTERNAL CONSULTANT ACTIVITY Advice from external consultants used on ad hoc basis GEPEC reviews the Safety, efficacy and pharmacological data provided in the submission dossier (CMED )Chamber of Drug Market Regulation discusses drug price with applicant CATEME ACTIVITY Technical chamber of medicines provides expert advice ANVISA carry out facility GMP inspection ANVISA approves the drug and grants marketing authorization

View entire presentation